Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov 10;14(11):e2000391.
doi: 10.1371/journal.pbio.2000391. eCollection 2016 Nov.

Animal Study Registries: Results from a Stakeholder Analysis on Potential Strengths, Weaknesses, Facilitators, and Barriers

Affiliations

Animal Study Registries: Results from a Stakeholder Analysis on Potential Strengths, Weaknesses, Facilitators, and Barriers

Susanne Wieschowski et al. PLoS Biol. .

Abstract

Publication bias in animal research, its extent, its predictors, and its potential countermeasures are increasingly discussed. Recent reports and conferences highlight the potential strengths of animal study registries (ASRs) in this regard. Others have warned that prospective registration of animal studies could diminish creativity, add administrative burdens, and complicate intellectual property issues in translational research. A literature review and 21 international key-informant interviews were conducted and thematically analyzed to develop a comprehensive matrix of main- and subcategories for potential ASR-related strengths, weaknesses, facilitators, and barriers (SWFBs). We identified 130 potential SWFBs. All stakeholder groups agreed that ASRs could in various ways improve the quality and refinement of animal studies while allowing their number to be reduced, as well as supporting meta-research on animal studies. However, all stakeholder groups also highlighted the potential for theft of ideas, higher administrative burdens, and reduced creativity and serendipity in animal studies. Much more detailed reasoning was captured in the interviews than is currently found in the literature, providing a comprehensive account of the issues and arguments around ASRs. All stakeholder groups highlighted compelling potential strengths of ASRs. Although substantial weaknesses and implementation barriers were highlighted as well, different governance measures might help to minimize or even eliminate their impact. Such measures might include confidentiality time frames for accessing prospectively registered protocols, harmonized reporting requirements across ASRs, ethics reviews, lab notebooks, and journal submissions. The comprehensive information gathered in this study could help to guide a more evidence-based debate and to design pilot tests for ASRs.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Visualization of core SWFBs.

Comment in

References

    1. Prinz F, Schlange T, Asadullah K. Believe it or not: how much can we rely on published data on potential drug targets? Nature reviews Drug discovery. 2011;10(9):712 10.1038/nrd3439-c1 . - DOI - PubMed
    1. Hackam DG, Redelmeier DA. Translation of research evidence from animals to humans. Jama. 2006;296(14):1731–2. 10.1001/jama.296.14.1731 . - DOI - PubMed
    1. Muller KF, Briel M, D'Amario A, Kleijnen J, Marusic A, Wager E, et al. Defining publication bias: protocol for a systematic review of highly cited articles and proposal for a new framework. Systematic reviews. 2013;2:34 10.1186/2046-4053-2-34 - DOI - PMC - PubMed
    1. Blumle A, von Elm E, Antes G, Meerpohl JJ. [Measurement and assessment of study quality and reporting quality]. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen. 2014;108(8–9):495–503. 10.1016/j.zefq.2014.09.022 . - DOI - PubMed
    1. Kasenda B, Schandelmaier S, Sun X, von Elm E, You J, Blumle A, et al. Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications. BMJ. 2014;349:g4539 10.1136/bmj.g4539 - DOI - PMC - PubMed

LinkOut - more resources